CAJ | 학술논문

目的：探讨未足月胎膜早破发生因素及妊娠结局。方法对研究组与对照组未足月胎膜早破患者临床资料进行回顾性分析，探讨未足月胎膜早破相关发生因素，记录两组分娩方式及母婴结局，给予统计学分析后得出结论。结果生殖道感染、引流产史、妊娠期高血压综合征属于未足月胎膜早破主要发生因素，所占比例分别为23.81%、20.24%、16.67%（P ＜0.05）；研究组未足月胎膜早破患者行剖宫产分娩率高达46.43%，显著高于对照组足月胎膜早破患者剖宫产率29.76%；研究组新生儿并发症发生率及死亡率均高于对照组（P ＜0.05）；两组新生儿性别对比结果并无统计学差异（P ＞0.05）；对照组新生儿 Apgar 评分为（8.98±0.56）分，研究组 Apgar 评分为（5.64±0.39）分，研究组明显不及对照组（P ＜0.05）。结论临床医生应准确掌握未足月胎膜早破临床特征，对疑似病例尽快确诊并给予积极治疗，有效保障母婴生活质量及生命安全。
목적：탐토미족월태막조파발생인소급임신결국。방법대연구조여대조조미족월태막조파환자림상자료진행회고성분석，탐토미족월태막조파상관발생인소，기록량조분면방식급모영결국，급여통계학분석후득출결론。결과생식도감염、인유산사、임신기고혈압종합정속우미족월태막조파주요발생인소，소점비례분별위23.81%、20.24%、16.67%（P ＜0.05）；연구조미족월태막조파환자행부궁산분면솔고체46.43%，현저고우대조조족월태막조파환자부궁산솔29.76%；연구조신생인병발증발생솔급사망솔균고우대조조（P ＜0.05）；량조신생인성별대비결과병무통계학차이（P ＞0.05）；대조조신생인 Apgar 평분위（8.98±0.56）분，연구조 Apgar 평분위（5.64±0.39）분，연구조명현불급대조조（P ＜0.05）。결론림상의생응준학장악미족월태막조파림상특정，대의사병례진쾌학진병급여적겁치료，유효보장모영생활질량급생명안전。
Objective To investigate the occurrence of PPROM factors and pregnancy outcome. Methods After the study group and the control group PPROM clinical data were retrospectively analyzed to explore the occurrence of PPROM relevant factors, recording two mode of delivery and maternal and child outcomes, given the statistical analysis results in conclusion. Results Reproductive tract infections, cited abortion, pregnancy-induced hypertension are the main factors PPROM occurs, the proportion was 23.81%, 20.24%, 16.67% (P < 0.05); preterm study group premature rupture of membranes underwent cesarean delivery rate of up to 46.43%, significantly higher in patients with premature rupture of membranes at term cesarean rate 29.76%; study group of neonatal morbidity and mortality were higher (P < 0.05); there was no significant difference between the two groups of neonatal sex comparative results (P > 0.05);Apgar score of the control group was (8.98±0.56) points, the study group's Apgar score was (5.64±0.39) points, the study group was significantly less than the control group (P < 0.05). Conclusion Clinicians should accurately grasp PPROM clinical features, diagnosis of suspected cases and given active treatment as soon as possible, effectively guaranteeing the quality of life and the lives of mother and child.